Circle Medical and One Medical both describe menopause treatment as part of primary care. Circle's published self-pay model charges per appointment without membership; One Medical's standard membership supports access while scheduled visits are billed separately.
We checked official pages September 21, 2026 without joining either practice. This is a comparison of published care arrangements, not individual coverage or patient results. CoreAge's separate banner remains promotional with menopause HRT availability unconfirmed.
In this entry
Decide what you need from primary care
If you want menopause concerns considered alongside other medical issues, ask which clinician and appointment can accommodate that discussion. A primary-care service may coordinate assessment and referrals, but its name does not establish identical menopause expertise among all providers.
Read the Circle Medical review and One Medical review with your preferred care relationship in mind. Consider whether an office connection, an ongoing clinician or a particular visit format is essential to you.
Put the fees in the correct columns
Circle advertises $120 self-pay appointments and no membership fee. One Medical's standard personal membership is $199 annually, with scheduled video and office visits separately billed. The first figure purchases an appointment; the second describes access under one enrollment route.
Ask for the initial assessment and expected follow-up charges under the plan actually offered. Employer funding or another One Medical rate may change the membership input. The cost worksheet should use actual charges in the comparison period, not an annual equivalent mistaken for the amount due today.
Read the boundaries of included contact
One Medical distinguishes on-demand services from scheduled visits and says some long-term prescriptions require a booked office or video appointment. Confirm whether your HRT assessment or refill falls in that category. Membership alone is not proof that ongoing treatment is entirely included.
For Circle, ask when a treatment question requires another appointment and whether between-visit messaging is available for the issue. No recurring access fee does not mean every future review is free. Compare the support expected under the actual clinical plan.
Verify eligibility and the pharmacy bill
Circle's menopause page describes availability in 32 states and excludes Medicaid/Medi-Cal patients even for self-pay. One Medical's local offices, clinician availability and insurance participation also need checking. A broad brand presence does not confirm a usable appointment.
The insurance shortlist helps separate network participation from personal benefits. Medication and laboratory costs may remain outside the clinical charge. An average insured cost should not replace your own benefit estimate.
Keep product selection with the clinician
Both services describe possible hormonal and nonhormonal treatment after evaluation. Ask what the actual prescription would contain and why. Do not assume either primary-care model necessarily means compounded treatment or an identical formulary.
Use the online-care checklist to bring current medicines, surgery details and symptoms into the assessment. If you already use HRT, clarify which records are needed before a clinician can decide whether to continue it.
Compare a workable continuing plan
Circle may be worth investigating when paying per appointment fits your preferences. One Medical may be worth investigating when its membership-supported primary care and office access fit. The no-membership shortlist provides further alternatives for the first preference.
The conclusion should depend on a suitable available clinician, the full bill and an explicit follow-up arrangement. Neither fee structure proves greater medical effectiveness. Confirm the next prescription responsibility before canceling an existing source of care.
CHECK THE ORIGINAL
The source record
Provider pages document their own offers. Medical and regulatory sources provide treatment context. This is not a record of personal patient testing. Latest source check: September 21, 2026.